uuid:
  -
    value: a09531e3-7e48-4d7c-b891-9657a5b8e711
langcode:
  -
    value: und
type:
  -
    target_id: case_series
    target_type: node_type
    target_uuid: 0ea0fe3a-e616-4d45-88b7-f6bb126fd852
revision_timestamp:
  -
    value: '2016-07-27T22:17:47+00:00'
    format: 'Y-m-d\TH:i:sP'
revision_uid:
  -
    target_type: user
    target_uuid: 7f2b027c-635a-47bd-9500-94902c2d3670
revision_log: {  }
status:
  -
    value: true
uid:
  -
    target_type: user
    target_uuid: 7f2b027c-635a-47bd-9500-94902c2d3670
title:
  -
    value: 'Investing in the Indian Pharmaceutical Industry'
created:
  -
    value: '2016-07-27T22:17:47+00:00'
    format: 'Y-m-d\TH:i:sP'
changed:
  -
    value: '2016-07-27T22:17:47+00:00'
    format: 'Y-m-d\TH:i:sP'
promote:
  -
    value: false
sticky:
  -
    value: false
default_langcode:
  -
    value: true
revision_translation_affected:
  -
    value: true
path:
  -
    alias: /faculty-and-research/case-series/id/a03-99-0015
body:
  -
    value: '<div class="field field-name-body field-type-text-with-summary field-label-above"><div class="field-items"><div class="field-item even"><p>In 1991 India reversed a traditional policy that had restricted direct foreign investment and introduced a regime that welcome it. Many foreign companies that had previously avoided India started to invest with great enthusiasm. Yet participation by multinational pharmaceutical firms was conspicuously absent. The case examines the pharmaceutical industry in India and concludes that the absence of effective patent protection for pharmaceutical products was a major reason for the lack of investment in this sector in India.</p><p>&nbsp;</p></div></div></div>'
    format: basic_html
    processed: ''
    summary: ''
    summary_processed: ''
field_case_number:
  -
    value: A03-99-0015
field_case_page_length:
  -
    value: '15 pages'
field_case_series_author:
  - {  }
field_case_series_date: {  }
field_case_series_image: {  }
field_case_series_industry:
  -
    target_type: taxonomy_term
    target_uuid: 13096043-8dd0-4a05-ae37-8f09da97fdae
field_case_series_year:
  -
    value: '1999-01-01'
field_case_setting:
  -
    value: 'India, 1990s'
field_case_source:
  -
    value: 'Field case'
field_case_subject:
  -
    target_type: taxonomy_term
    target_uuid: 07d7612c-2805-48a1-a6a9-b66ec0ffdfa9
  -
    target_type: taxonomy_term
    target_uuid: 0916fe63-addb-4124-9ec0-5e09e8c3100b
  -
    target_type: taxonomy_term
    target_uuid: 62842b00-92e7-4e68-8287-e378f06afca3
field_fields:
  -
    target_type: taxonomy_term
    target_uuid: 17887499-570f-4bb0-8701-53a0ccfd82a2
field_teaching:
  -
    value: "This case can be used in any class dealing with intellectual property or direct foreign investment, and would be particularly useful in demonstrating the contrasting views between developed and developing countries. Class discussion should include the drafting of a new patent law for India, complying with TRIPS, yet maintaining sufficient flexibility to assure manageable pricing for the Indian consumer. Some prior knowledge by the students of intellectual property issues and regulating foreign direct investment would enhance the value of the case. The case is also applicable to discussions of the pharmaceutical industry as it illustrates the importance of patent protection to the construction and maintenance of competitive positioning in that industry.\r\n\r\n"
_content_sync:
  entity_type: node
  entity_dependencies:
    user:
      - user.user.7f2b027c-635a-47bd-9500-94902c2d3670
    taxonomy_term:
      - taxonomy_term.case_series_industry.13096043-8dd0-4a05-ae37-8f09da97fdae
      - taxonomy_term.case_series_categories.07d7612c-2805-48a1-a6a9-b66ec0ffdfa9
      - taxonomy_term.case_series_categories.0916fe63-addb-4124-9ec0-5e09e8c3100b
      - taxonomy_term.case_series_categories.62842b00-92e7-4e68-8287-e378f06afca3
      - taxonomy_term.case_series_fields.17887499-570f-4bb0-8701-53a0ccfd82a2
